Home Cushing syndrome related to leukemic infiltration of the central nervous system: a case report and a possible role of LIF
Article
Licensed
Unlicensed Requires Authentication

Cushing syndrome related to leukemic infiltration of the central nervous system: a case report and a possible role of LIF

  • Nursel Muratoglu Sahin EMAIL logo , Zekai Avci , Baris Malbora , Ayhan Abaci , Sibel Tulgar Kinik and Namik Yasar Ozbek
Published/Copyright: May 17, 2013

Abstract

Background: Adrenocorticotropic hormone (ACTH)-dependent Cushing syndrome (CS) in the presence of leukemic central nervous system infiltration is very rare.

Case: A 3.8-year-old girl who had been treated for B-cell acute lymphoblastic leukemia (ALL) for 1.5 years was admitted to our hospital with excessive weight gain and depression for the last 2 months. Prior to her admission, she was on maintenance with the ALL-BFM95 study protocol for 10 months that does not contain corticosteroids. On physical examination, central obesity and moon face appearance were determined. Laboratory tests revealed high morning ACTH, cortisol level, and 24-h urinary free cortisol level. Morning cortisol level was 33.94 nmol/L after a 2-day (4×0.5 mg) dexamethasone suppression test. A lumbar puncture revealed leukemic cells in the cerebrospinal fluid. No pituitary adenoma was detected on magnetic resonance imaging. We diagnosed the patient with ACTH-dependent CS related to leukemic infiltration of the central nervous system.

Conclusion: Central nervous system infiltration should be considered in leukemic patients who have developed CS. We believe increased leukemia inhibitory factor levels may be a factor for CS in our patient with ALL.


Corresponding author: Nursel Muratoglu Sahin, Department of Pediatric Endocrinology, School of Medicine, Baskent University, Fevzi Cakmak Cad. 10. Sokak No: 45, 06490 Bahcelievler, Ankara, Turkey, Phone: +90-312-215-21-14, Fax: +90-312-215-75-97, E-mail:

References

1. Lindholm JF, Juul S, Jørgensen JO, Astrup J, Bjerre P, et al. Incidence and late prognosis of Cushing’s syndrome: a population-based study. J Clin Endocrinol Metab 2001;86:117–23.10.1210/jc.86.1.117Search in Google Scholar

2. Magiakou MA, Chrousos GP. Cushing’s syndrome in children and adolescents: current diagnostic and therapeutic strategies. J Endocrinol Invest 2002;25:181–94.10.1007/BF03343985Search in Google Scholar

3. Savage MO, Besser GM. Cushing’s disease in childhood. Trends Endocrinol Metab 1996;7:213–6.10.1016/1043-2760(96)00089-6Search in Google Scholar

4. Magiakou MA, Mastorakos G, Oldfield EH, Gomez MT, Doppman JL, et al. Cushing’s syndrome in children and adolescents. Presentation, diagnosis and therapy. N Engl J Med 1994;331:629–36.10.1056/NEJM199409083311002Search in Google Scholar

5. Newell-Price JF, Trainer PF, Besser MF, Grossman AB. The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev 1998;19:647–72.Search in Google Scholar

6. Nieman LK. Diagnostic tests for Cushing’s syndrome. Ann NY Acad Sci 2002;970:112–8.10.1111/j.1749-6632.2002.tb04417.xSearch in Google Scholar

7. Boscaro MF, Barzon LF, Fallo FF, Sonino N. Cushing’s syndrome. Lancet 2001;357:783–91.10.1016/S0140-6736(00)04172-6Search in Google Scholar

8. Stratakis CA. Adrenocortical tumors, primary pigmented adrenocortical disease (PPNAD)/Carney complex, and other bilateral hyperplasias: the NIH studies. Horm Metab Res 2007;39:467–73.10.1055/s-2007-981477Search in Google Scholar

9. Gunther DF, Bourdeau I, Matyakhina L, Cassarino D, Kleiner DE, et al. Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity? J Clin Endocrinol Metab 2004;89:3173–82.10.1210/jc.2003-032247Search in Google Scholar

10. Savage MO, Lienhardt AF, Lebrethon MC, Johnston LB, Huebner A, et al. Cushing’s disease in childhood: presentation, investigation, treatment and long-term outcome. Horm Res 2001;55:24–30.10.1159/000063459Search in Google Scholar

11. Normann T, Hanven J, Mjolnerod O. Cushing syndrome in an infant associated with neuroblastoma in two ectopic adrenal glands. J Pediatr Surg 1971;6:169–75.10.1016/0022-3468(71)90313-7Search in Google Scholar

12. Arioglu E, Doppman J, Gomes M, Kleiner D, Mauro D, et al. Cushing’s syndrome caused by corticotropin secretion by pulmonary tumorlets. N Engl J Med 1998;339:883–6.10.1056/NEJM199809243391304Search in Google Scholar

13. Arnaldi GF, Angeli AF, Atkinson AB, Bertagna X, Cavagnini F, et al. Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 2003;88: 5593–602.10.1210/jc.2003-030871Search in Google Scholar

14. Magiakou MA, Mastorakos G, Chrousos GP. Final stature in patients with endogenous Cushing’s syndrome. J Clin Endocrinol Metab 1994;79:1082–5.Search in Google Scholar

15. Lebrethon MC, Grossman AB, Afshar FF, Plowman PN, Besser GM, et al. Linear growth and final height after treatment for Cushing’s disease in childhood. J Clin Endocrinol Metab 2000;85:3262–5.Search in Google Scholar

16. Kudielka BM, Buske-Kirschbaum A, Hellhammer DH, Kirschbaum C. HPA axis responses to laboratory psychosocial stress in healthy elderly adults, younger adults, and children: impact of age and gender. Psychoneuroendocrinology 2004;29:83–98.10.1016/S0306-4530(02)00146-4Search in Google Scholar

17. Kuperman H, Damiani D, Chrousos GP, Dichtchekenian V, Manna TD, et al. Evaluation of the hypothalamic-pituitary-adrenal axis in children with leukemia before and after 6 weeks of high-dose glucocorticoid therapy. J Clin Endocrinol Metab 2001;86:2993–6.10.1210/jcem.86.7.7629Search in Google Scholar

18. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 2006;6:193–203.10.1038/nrc1816Search in Google Scholar

19. Barredo J, Ritchey AK. Controversies in the management of central nervous system leukemia. Pediatr Hematol Oncol 2010;27:329–32.10.3109/08880011003758422Search in Google Scholar

20. Talıaferro I. Cushing’s syndrome associated with acute leukemia. South Med J 1961;54:686–9.10.1097/00007611-196106000-00021Search in Google Scholar

21. Pflüger KH, Gramse M, Gropp C, Havemann K. Ectopic ACTH production with autoantibody formation in a patient with acute myeloblastic leukemia. N Engl J Med 1981;305:1632–6.10.1056/NEJM198112313052706Search in Google Scholar

22. Tilley E, Ryalls MR, Williams MP. CT demonstration of pituitary stalk relapse in childhood acute lymphoblastic leukaemia. Clin Radiol 1989;40:634–5.10.1016/S0009-9260(89)80330-7Search in Google Scholar

23. Muller CI, Engelhardt M, Laubenberger J, Kunzmann R, Engelhardt R, et al. Myelodysplastic syndrome in transformation to acute myeloid leukemia presenting with diabetes insipidus: due to pituitary infiltration association with abnormalities of chromosomes 3 and 7. Eur J Haematol 2002;69:115–9.10.1034/j.1600-0609.2002.02763.xSearch in Google Scholar PubMed

24. Rye AD, Stitson RN, Dyer MJ. Pituitary infiltration in B cell chronic lymphocytic leukaemia. Br J Haematol 2001;115:718.10.1046/j.1365-2141.2001.03210.xSearch in Google Scholar

25. Shek TW, Au WY. Conjunctival relapse of acute lymphoblastic leukemia heralding pituitary and CNS disease. J Clin Oncol 2005;23:4225–30.10.1200/JCO.2005.04.133Search in Google Scholar

26. Nemoto K, Ohnishi Y, Tsukada T. Chronic lymphocytic leukemia showing pituitary tumor with massive leukemic cell infiltration, and special reference to clinicopathological findings of CLL. Acta Pathol Japon 1978;28:797–805.10.1111/j.1440-1827.1978.tb00918.xSearch in Google Scholar

27. Metcalf D. The unsolved enigmas of leukemia inhibitory factor. Stem Cells 2003;21:5–14.10.1634/stemcells.21-1-5Search in Google Scholar

28. Tomida M, Yamamoto-Yamaguchi Y, Hozumi M. Purification of a factor inducing differentiation of mouse myeloid leukemic Ml cells from conditioned medium of mouse fibroblast L929 cells. J Biol Chem 1984;259:10978–82.10.1016/S0021-9258(18)90609-5Search in Google Scholar

29. Metcalf D. Leukemia inhibitory factor-a puzzling polyfunctional regulator. Growth Factors 1992;7:169–73.10.3109/08977199209046921Search in Google Scholar PubMed

30. Sun H, Shi WK. Expression of LIF gene during early development of mouse embryo. J Exp Biol 1998;31:105–9.Search in Google Scholar

31. Fukada K, Korsching S, Towle MF. Tissue-specific and ontogenetic regulation of LIF protein levels determined by quantitative enzyme immunoassay. Growth Factors 1997;14:279–95.10.3109/08977199709021526Search in Google Scholar PubMed

32. Chesnokova V, Melmed S. Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation. Endocrinology 2000;141:4032–40.10.1210/endo.141.11.7778Search in Google Scholar PubMed

33. Ancey C, Corbi P, Froger J, Delwail A, Wijdenes J, et al. Secretion of IL-6, IL-11 and LIF by human cardiomyocytes in primary culture. Cytokine 2002;18:199–205.10.1006/cyto.2002.1033Search in Google Scholar PubMed

34. Morel DS, Taupin JL, Potier M, Deminière C, Potaux L, et al. Renal synthesis of leukaemia inhibitory factor (LIF), under normal and inflammatory conditions. Cytokine 2000;12: 265–71.10.1006/cyto.1999.0545Search in Google Scholar PubMed

35. Tofaris GK, Patterson PH, Jessen KR, Mirsky R. Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J Neurosci 2002;22:6696–703.10.1523/JNEUROSCI.22-15-06696.2002Search in Google Scholar

36. Bonifati C, Mussi A, D’Auria L, Carducci M, Trento E, et al. Spontaneous release of leukemia inhibitory factor and oncostatin-M is increased in supernatants of short-term organ cultures from lesional psoriatic skin. Arch Dermatol Res 1998;290:9–13.10.1007/s004030050269Search in Google Scholar PubMed

37. Chesnokova V, Kariagina A, Melmed S. Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation. Am J Physiol Endocrinol Met 2002;282:1110–8.10.1152/ajpendo.00442.2001Search in Google Scholar PubMed

38. Tomida M, Yoshida U, Mogi C, Maruyama M, Goda H, et al. Leukaemia inhibitory factor and interleukin 6 inhibit secretion of prolactin and growth hormone by rat pituitary MtT/SM cells. Cytokine 2001;14:202–7.10.1006/cyto.2001.0874Search in Google Scholar PubMed

39. Kendall SK, Gordon DF, Birkmeier TS, Petrey D, Sarapura VD, et al. Enhancer-mediated high level expression of mouse pituitary glycoprotein hormone a-subunit transgene in thyrotropes, gonadotropes, developing pituitary gland. Mol Endocrinol 1994;8:1420–33.Search in Google Scholar

40. Burrows HL, Birkmeier TS, Seasholtz AF, Camper SA. Targeted ablation of cells in the pituitary primordia of transgenic mice. Mol Endocrinol 1996;10:1467–77.Search in Google Scholar

41. Bousquet C, Ray DW, Melmed SA. Common proopiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy. J Biol Chem 1997;272:10551–7.10.1074/jbc.272.16.10551Search in Google Scholar PubMed

42. Ray DW, Ren SG, Melmed S. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. J Clin Invest 1996;97:1852–9.10.1172/JCI118615Search in Google Scholar PubMed PubMed Central

43. Xiao R, Chen T, Zhou M, Yang JH, Jiang NK, et al. Abnormal expression of hematopoietic regulatory factors in newly diagnosed patients with acute myeloid leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2010;18:1124–7.Search in Google Scholar

44. Wetzler M, Kurzrock R, Lowe DG, Kantarjian H, Gutterman JU, et al. Alteration in bone marrow adherent layer growth factor expression: a novel mechanism of chronic myelogenous leukemia progression. Blood 1991;78:2400–6.10.1182/blood.V78.9.2400.2400Search in Google Scholar

Received: 2012-12-14
Accepted: 2013-4-1
Published Online: 2013-05-17
Published in Print: 2013-10-01

©2013 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Review article
  4. Tamoxifen therapy for the management of pubertal gynecomastia: a systematic review
  5. Images in pediatric endocrinology
  6. Solitary median maxillary central incisor, a clinical predictor of hypoplastic anterior pituitary, ectopic neurohypophysis and growth hormone deficiency
  7. A rare case of granuloma annulare in a 6-year-old child with type 1 diabetes
  8. Original articles
  9. The arginine stimulation test: timing of peak is not a helpful parameter in the diagnosis of growth hormone deficiency
  10. The relationship between adiposity and stature in prepubertal children with celiac disease
  11. Influence of micronutrient status and socioeconomic gradient on growth indices of 2–18-year-old Indian girls
  12. Phosphotyrosine phosphatases in GH-stimulated skin fibroblasts from children with idiopathic short stature
  13. The relation between salivary cortisol and the metabolic syndrome score in girls
  14. Association of vitamin D concentrations with adiposity indices among preadolescent children in Korea
  15. Association of serum resistin levels with metabolic syndrome and early atherosclerosis in obese Chinese children
  16. Characteristics of infants at risk of hypoglycaemia secondary to being ‘infant of a diabetic mother’
  17. Parental dyadic coping in families of children and adolescents with type 1 diabetes
  18. Pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus (PHID) syndrome is associated with severe chronic inflammation and cardiomyopathy, and represents a new monogenic autoinflammatory syndrome
  19. Effect of insulin therapy on IGF-1 level in children with new-onset type 1 diabetes mellitus: a comparison between DKA and non-DKA
  20. Mutation analysis of the SRD5A2, AR and SF-1 genes in 52 Chinese boys with hypospadias
  21. Sexual development in prepubertal obese boys: a 4-year longitudinal study
  22. Genetic diagnosis of one family with incomplete clinical data
  23. Patient reports
  24. Complete androgen insensitivity syndrome and discordant Müllerian remnants: two cases with novel mutation in the androgen receptor
  25. Psychosexual outcomes in three siblings with partial androgen insensitivity syndrome: impact of nature versus nurture
  26. Ambiguous genitalia in a 48, XXYY newborn: a casual relationship or a coincidence?
  27. Gonadal function of beta-thalassemics following stem cell transplantation conditioned with myeloablative and reduced intensity regimens
  28. Significant testicular enlargement in a 6.5-year-old boy with monorchism and testicular microlithiasis
  29. Report of the first case of precocious puberty in Rett syndrome
  30. Type II vitamin D-dependent rickets with diabetic ketoacidosis
  31. Pituitary gigantism presenting with depressive mood disorder and diabetic ketoacidosis in an Asian adolescent
  32. A rare association between Rathke’s cyst and hypophysitis in a patient with delayed sex development and growth failure
  33. Diabetes mellitus with Laron syndrome: case report
  34. Wegener granulomatosis as an uncommon cause of panhypopituitarism in childhood
  35. Rare cases of autoimmune hypothyroidism in young children
  36. Cushing syndrome related to leukemic infiltration of the central nervous system: a case report and a possible role of LIF
  37. Early presentation of bilateral gonadoblastomas in a Denys-Drash syndrome patient: a cautionary tale for prophylactic gonadectomy
  38. Identification of a novel homozygous mutation (S144I) in a Malay patient with maple syrup urine disease
  39. Virilization in two pre-pubertal children exposed to topical androgen
  40. A family with Camurati-Engelman disease. The role of the missense p.R218C mutation in TGFB1 in bones and endocrine glands
  41. Short communications
  42. Plasma ceramides are elevated in female children and adolescents with type 2 diabetes
  43. Assessment of contractility and myocardial function in small and appropriate for gestational age premature neonates using the stress-velocity relationship and tissue Doppler imaging immediately after birth
  44. Letter to the Editors
  45. Homeostasis model assessment of insulin resistance may not be reliable to evaluate insulin sensitivity in young obese children
  46. Type 1 diabetes in women with endometriosis: what is the risk of occurrence?
  47. How should we manage vitamin D-deficient adolescents?
  48. Should neonatal hyperparathyroidism associated with mucolipidosis II/III be treated pharmacologically?a
Downloaded on 8.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2012-0401/html
Scroll to top button